Figure 1.
Participants’ flow. Eighty-eight participants in the study group were enrolled. Forty-four participants were assigned to CoronaVac/azd1222 group and 44 to AZD1222/CoronaVac group. Twenty participants lost to follow-up, 10 in CoronaVac/azd1222 group and 10 in AZD1222/CoronaVac group. a comparison group was collected from health care workers who completed 2 doses of CoronaVac and available immunogenicity data. 136 health care workers with age and sex matching were chosen for analysis.